Background Polycystic ovary syndrome (PCOS) is a complex syndrome with clinical features
of an endocrine/metabolic disorder. Various metabolites show significant association with …

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine and metabolic disorder,
affecting 5–10% of women of reproductive age. It results from complex environmental …

Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder
accompanied with an increased risk of developing type 2 diabetes mellitus and …

Metabolomics is the comprehensive assessment of endogenous metabolites of a biological
system in a holistic context. Threatened abortion in polycystic ovary syndrome (PCOS) is a …

Background Polycystic ovary syndrome (PCOS) is a complex reproductive endocrine
disorder. And metabolic syndrome (MS) is an important bridge for PCOS patients to develop …

Background: Polycystic ovary syndrome (PCOS) is a common reproductive disorder
associated with metabolic disturbances including obesity, insulin resistance and diabetes …

Polycystic ovary syndrome (PCOS) is an endocrinologic condition affecting one in five
women of reproductive age. PCOS is often characterized by disruptions to the menstrual …

Objective Polycystic ovary syndrome (PCOS) is a condition of androgen excess and chronic
anovulation frequently associated with insulin resistance. We combined a nontargeted and …

Background Polycystic ovary syndrome (PCOS) is not only a kind of common endocrine
syndrome but also a metabolic disorder, which harms the reproductive system and the …

Introduction Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder.
Hyperandrogenism (HA) and insulin resistance (IR) are two important pathogenic factors …